
NRXS Valuation
Neuraxis Inc
- Overview
- Forecast
- Valuation
- Earnings
NRXS Relative Valuation
NRXS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NRXS is overvalued; if below, it's undervalued.
Historical Valuation
Neuraxis Inc (NRXS) is now in the Overvalued zone, suggesting that its current forward PS ratio of 4.75 is considered Overvalued compared with the five-year average of -20.07. The fair price of Neuraxis Inc (NRXS) is between 0.64 to 1.56 according to relative valuation methord. Compared to the current price of 2.86 USD , Neuraxis Inc is Overvalued By 83.24%.
Relative Value
Fair Zone
0.64-1.56
Current Price:2.86
83.24%
Overvalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
81.19
P/B
Median3y
1.93
Median5y
1.93
-24.61
FCF Yield
Median3y
-35.11
Median5y
-35.11
Competitors Valuation Multiple
The average P/S ratio for NRXS's competitors is 1.37, providing a benchmark for relative valuation. Neuraxis Inc Corp (NRXS) exhibits a P/S ratio of 4.95, which is 260.21% above the industry average. Given its robust revenue growth of 38.51%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch

NXTT
Next Technology Holding Inc
2.410
USD
+2.55%

MEIP
MEI Pharma Inc
6.200
USD
-9.62%

DUO
Fangdd Network Group Ltd
2.250
USD
-3.02%

BOLT
Bolt Biotherapeutics Inc
6.710
USD
+12.77%

XTIA
XTI Aerospace Inc
2.220
USD
+5.21%

WETH
Wetouch Technology Inc
0.920
USD
+2.22%

SANW
S&W Seed Co
2.110
USD
-2.31%

COHN
Cohen & Company Inc
12.330
USD
+2.66%

COEP
Coeptis Therapeutics Holdings Inc
12.310
USD
+12.83%

GOEV
Canoo Inc
0.370
USD
0.00%
FAQ

Is Neuraxis Inc (NRXS) currently overvalued or undervalued?
Neuraxis Inc (NRXS) is now in the Overvalued zone, suggesting that its current forward PS ratio of 4.75 is considered Overvalued compared with the five-year average of -20.07. The fair price of Neuraxis Inc (NRXS) is between 0.64 to 1.56 according to relative valuation methord. Compared to the current price of 2.86 USD , Neuraxis Inc is Overvalued By 83.24% .

What is Neuraxis Inc (NRXS) fair value?

How does NRXS's valuation metrics compare to the industry average?

What is the current P/B ratio for Neuraxis Inc (NRXS) as of Jul 24 2025?

What is the current FCF Yield for Neuraxis Inc (NRXS) as of Jul 24 2025?

What is the current Forward P/E ratio for Neuraxis Inc (NRXS) as of Jul 24 2025?
